DOH FDA Kapihan at Talakayan: Dialogue with the Secretary of Health and Director General of the Food and Drug Administration on Regulatory Matters - SPIK
The Samahan sa Pilipinas ng mga Industriyang Kimika (SPIK), together with the different industry associations with products under the FDA, was invited to the DOH FDA Kapihan at Talakayan: Dialogue with the Secretary of Health and Director General of the Food and Drug Administration on Regulatory Matters at the FDA office.
DOH, DFA, Kapihan at Talakayan, Secretary of Health, Director General of the Food and Drug Administration
16702
post-template-default,single,single-post,postid-16702,single-format-standard,bridge-core-1.0.5,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

DOH FDA Kapihan at Talakayan: Dialogue with the Secretary of Health and Director General of the Food and Drug Administration on Regulatory Matters

DOH FDA Kapihan at Talakayan

10 Jul DOH FDA Kapihan at Talakayan: Dialogue with the Secretary of Health and Director General of the Food and Drug Administration on Regulatory Matters

Posted at 01:05h in RC News by
Spread the love

The Samahan sa Pilipinas ng mga Industriyang Kimika (SPIK), together with the different industry associations with products under the FDA, was invited to the DOH FDA Kapihan at Talakayan: Dialogue with the Secretary of Health and Director General of the Food and Drug Administration on Regulatory Matters at the FDA office. The session for industry associations under the Center for Cosmetic Regulation and Research (CCRR), which includes products classified as Household Hazardous Urban Substances (HHUS) was held last July 17 9-11am.

In his opening remarks, Dr. Kenneth Hartigan- Go shares the three objectives of the DOH as increase the healthcare spending, rationalize procurement of healthcare equipment, services, products and facilities and regulatory alignment. According to Dr. Hartigan- Go, it is very important to hear and listen to the concerns of the industry.

During the meeting DoH Secretary Janette Garin, who’s also concurrently Director General of the FDA, announced that the DOH is in the process of removing certain items from the list of Household Hazardous Urban Substances (HHUS). Together with DoH Undersecretary (and former FDA Director General) Kenneth Hartigan- Go, they announced that in order to facilitate the private sector, products that were deemed to be minimal hazard and risk to the public would no longer need to comply with FDA requirements such as license to operate, product registration or notification, and full ingredient disclosure.